Dialogues with experts. Cognitive impairment in patients as an interdisciplinary problem
Vladimir Vladimirovich Zakharov , Doctor of Medical Sciences, Professor of the Department of Nervous System Diseases and Neurosurgery at the N.V. Sklifosovsky Institute of Cardiology and Microbiology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
Anna Nikolaevna Bogolepova , Doctor of Medical Sciences, Professor of the Department of Neurology, Neurosurgery, and Medical Genetics of the Federal State Autonomous Educational Institution of Higher Education, the N.I. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Head of the Department of Cognitive Impairments of the Federal Center for Medical Sciences, Federal Medical and Biological Agency of Russia
Announcement:
Cognitive impairment is one of the most common, yet often overlooked, problems in modern medicine. It affects 40% of people over 65 and is increasingly common in middle-aged patients. Why has this become such a cross-disciplinary issue? How can early symptoms be detected? And which treatments actually work? Professors Vladimir Vladimirovich Zakharov and Anna Nikolaevna Bogolepova.
Key topics of the video lecture:
- Why is cognitive impairment not just “senile forgetfulness”?
— How hypertension, diabetes and stress destroy the brain.
— Why do 50% of patients with high blood pressure not feel symptoms, but already have cognitive deficits?
- Diagnostics: from simple tests to MRI
— Gold standard: MoCA test.
— What methods will help assess attention and planning?
— When should you refer to a neurologist, and when can a therapist or general practitioner handle it?
- Treatment Strategies: From Risk Correction to Neuroprotection
— Why is it not enough to simply lower blood pressure or cholesterol?
— Multimodal therapy: how to protect neurons and improve blood flow.
— Efficacy of the drug Mexidol: data from the MEMO study.
- Clinical guidelines 2024
— Which drugs were included in the updated Clinical Guidelines and why.
— How can comorbid patients avoid polypharmacy?
Who is this video for?
- Therapists, cardiologists, endocrinologists - how to identify cognitive impairment in patients with hypertension, diabetes and atherosclerosis.
- General practitioners - patient routing and basic therapy.
- Neurologists and psychiatrists - modern diagnostic and therapeutic algorithms.
Key takeaway: Cognitive impairment is not a death sentence. Early diagnosis, management of vascular risks, and pathogenetic therapy (for example, the inclusion of Mexidol) can slow progression and improve quality of life. The human brain needs protection no less than the heart or blood vessels!